Pharmacy Times
NOVEMBER 23, 2024
Intravenous immunoglobulin (IVIG) has proven efficacy in autoimmune neuropathies, with mixed but promising outcomes in severe COVID-19 cases and post-acute sequelae of SARS-CoV-2 infection trials.
STAT
NOVEMBER 27, 2024
Two years ago, the RSV epidemic shook pediatric hospitals across the country along with the pediatric residents in them. One of us, Faith, was a resident at the time, and she and her colleagues refer to it as the dark ages : Whether they were arriving for their morning shifts or leaving their night shifts, the number of patients they took care of would not change for weeks at a time.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
NOVEMBER 29, 2024
Jay Holloway, PharmD, AAHIVP, Pharmacist with the AIDS Healthcare Foundation, discussed the ongoing developments impacting patients with HIV and their prescription drugs.
Fierce Healthcare
NOVEMBER 26, 2024
The Centers for Medicare & Medicaid Services (CMS) finalized a six-year mandatory model to increase access to kidney transplants, the agency announced Nov. 26. | CMS made some concessions to hospitals who strongly criticized the kidney transplant model proposed rule in May.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
NOVEMBER 26, 2024
Pharmacists play a vital role in multidisciplinary health care teams by enhancing medication safety, optimizing therapeutic outcomes, expanding medication access, reducing costs, and improving patient education.
STAT
NOVEMBER 29, 2024
YouTube plays a unique role in people’s everyday lives, says Garth Graham, the company’s global head of healthcare and public health. “People come to us to learn how to fix their fridge and to learn about medicines,” he said in an interview. “There’s a lot of responsibility, and we take that seriously. Responsibility is at the core of how YouTube works and how we treat sensitive information, particularly around health.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
NOVEMBER 26, 2024
The Centers for Medicare & Medicaid Services (CMS) is attempting to cover anti-obesity medications under Medicare Part D and Medicaid, the agency announced Nov. 26. | With time running out before leaving office, the Biden administration is proposing a rule to have Medicare and Medicaid cover anti-obesity medications and bolster guardrails for AI, among the changes.
Pharmacy Times
NOVEMBER 29, 2024
Pneumococcal disease incidence decreased in adults after pneumococcal vaccines began to be used in children due to indirect protection, with fewer adults found to carry the bacterium that causes disease.
STAT
NOVEMBER 25, 2024
UnitedHealth Group is paying many of its own physician practices significantly more than it pays other doctor groups in the same markets for similar services, undermining competition and driving up costs for consumers and businesses, a STAT investigation reveals. The findings, drawn from a sample of practices across the country, expose the effects of a deepening conflict of interest: Rather than use its size and market power to drive down the cost of care, UnitedHealth, as the corpor
Fierce Pharma
NOVEMBER 25, 2024
Incyte’s previously disclosed phase 3 win in relapsed or refract | In the phase 3 inMIND study, Monjuvi—added to Bristol Myers Squibb's Revlimid and Roche's Rituxan—triggered a 57% reduction in the risk of disease progression, relapse or death in R/R FL patients compared with those who were treated with placebo, Revlimid and Rituxan.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
NOVEMBER 25, 2024
Teladoc Health launched an AI-enabled technology that allows hospital staff to virtually detect when a patient is at risk of falling from a hospital bed. | Teladoc Health launched its new motion detection solution, vSitter, which allows staff to virtually observe patients and detect if they are at risk of falling out of the hospital bed. The advanced AI solution uses computer vision, motion detection, pose estimation and spatial boundaries to predict if patients are at risk of harm.
Pharmacy Times
NOVEMBER 28, 2024
Researchers developed a method to stabilize respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) fusion (F) proteins, advancing potential vaccines for both viruses.
STAT
NOVEMBER 24, 2024
Health officials in California have discovered bird flu virus in raw milk for sale in a store in the state, a development scientists following the ongoing outbreak of bird flu in dairy cows have been anticipating and worrying about for some time. While the human health implications of drinking H5N1-laced milk are unknown, scientists who study the virus have been fearful of what consuming milk containing the virus could do.
Fierce Pharma
NOVEMBER 26, 2024
While Novartis has largely wrapped up its transformation into a leaner innovative medicines company—which included multiple rounds of staff cuts over the years—employment changes are still afoot at | Novartis is laying off a total of 139 staffers in East Hanover, New Jersey, where the company’s U.S. headquarters is located. The move will primarily affect commercial field sales associates working on the brands Xolair for asthma and allergies and the oncology combo made up of kinase inhibitors Taf
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
NOVEMBER 26, 2024
Providers are rapidly adopting generative AI-based clinical documentation tools to aid clinicians and make digital paperwork more efficient. | Cambridge Health Alliance, the only public academic health system in Massachusetts, is deploying Abridge's AI-based medical note-taking tool across its 600 clinicians after a successful pilot.
Pharmacy Times
NOVEMBER 27, 2024
These findings are significant in understanding interactions between glucagon-like peptide-1 medications and thyroid dysfunction because prior research has shown conflicting results.
STAT
NOVEMBER 25, 2024
Four years on, the Cassava Sciences story ended Monday exactly as many knew it would — with the company’s experimental drug for Alzheimer’s disease, simufilam, proving to be nothing more than a placebo in a large clinical trial. The negative outcome is devastating for the nearly 2,000 participants in this study and a second study also shut down Monday.
Fierce Pharma
NOVEMBER 25, 2024
Eight months after snaring an inaugural FDA green light, Merck & Co. is bolstering the case for the chief asset in its $11.5 billion Acceleron acquisition. | In the phase 3 ZENITH study, Merck’s activin signaling inhibitor Winrevair met its primary endpoint of time to first morbidity or mortality event, which included all-cause death, lung transplantation, or hospitalization for at least 24 hours linked to disease worsening in patients with PAH.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Topics
NOVEMBER 26, 2024
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, talks about the best ways pharmacists can stay updated on advancements in diabetes medications and treatments.
Pharmacy Times
NOVEMBER 27, 2024
In trials, blood pressure reductions were maintained over extended periods, suggesting that the drug could offer a sustained effect.
STAT
NOVEMBER 27, 2024
Vanessa Kerry, a pulmonary and critical care physician, founded Seed Global Health more than a decade ago to tackle inequities in health care systems around the world, especially in countries with fewer resources. Climate change is exacerbating these disparities, she told STAT in an interview, as is our inability to address the crisis with the urgency it demands.
Fierce Pharma
NOVEMBER 25, 2024
On a Zoom call last month from California, BridgeBio CEO Neil Kumar needled a colleague about the remote possibility of the New York Yankees rallying to win the World Series as they trailed the Los | The FDA has signed off on BridgeBio's Attruby (acoramidis), a potential blockbuster to treat patients with the rare heart disease transthyretin amyloid cardiomyopathy.
Drug Topics
NOVEMBER 28, 2024
Steve Callahan, Senior Director of Advisory & Insights at MMIT, sat down with Drug Topics to discuss industry trends behind biosimilars.
Pharmacy Times
NOVEMBER 27, 2024
Trends across small cell lung cancer (SCLC) and diffuse large B-cell lymphoma (DLBCL) emphasize the need to further improve global treatment options.
STAT
NOVEMBER 26, 2024
Recursion Pharmaceuticals, one of the most advanced companies using artificial intelligence and machine learning tools to expedite drug development , laid off employees after closing a merger last week.
Fierce Healthcare
NOVEMBER 25, 2024
UnitedHealthcare successfully won its lawsuit over the Centers for Medicare and Medicaid Services, a federal judge determined Nov. 22. | UnitedHealthcare will get to claim victory over CMS for its star ratings lawsuit win. The insurer will receive a recalculated score from the federal agency, potentially giving the insurer more in quality bonus payments.
Drug Topics
NOVEMBER 27, 2024
A recent study found that there was a significant relationship between self-efficacy for disease control and the level of glycemic control.
Pharmacy Times
NOVEMBER 27, 2024
The approval is based on clinical studies that demonstrate the management of heart rate with minimal reductions to blood pressure.
STAT
NOVEMBER 26, 2024
LONDON — Policymakers and scientific groups need to specify guidelines for the burgeoning field that uses stem cells to mimic aspects of embryonic development, including by establishing certain red lines on research, an influential U.K. bioethics group said Wednesday in a new report. Specifically, the report from the Nuffield Council on Bioethics says that researchers should not use these stem cell-based embryo models to try to start a pregnancy in a person or animal, and should not
Fierce Pharma
NOVEMBER 27, 2024
The competition among three TROP2 antibody-drug conjugates is ent | The competition among three TROP2 antibody-drug conjugates is entering a new stage as Kelun-Biotech’s Merck & Co.-partnered sacituzumab tirumotecan has become the second therapy in the class to win a marketing approval.
Drug Topics
NOVEMBER 26, 2024
Benjamin Jolley, PharmD, pharmacist at Jolley’s Compounding Pharmacy in Salt Lake City, Utah, discussed the state of independent pharmacy.
Pharmacy Times
NOVEMBER 27, 2024
Evidence suggests that precautionary measures in elementary schools were able to effectively mitigate large increases in disease transmission.
STAT
NOVEMBER 26, 2024
New data from a mid-stage study of an Amgen obesity drug showed that it helped participants lose a substantial amount of weight, but questions about how competitive it could be appear to be shaping the response to the news, with the company’s share price falling on the announcement. Amgen said Tuesday that that its drug, MariTide , led to an average of roughly 20% weight loss over a year in the Phase 2 study in participants who had obesity or who were overweight without type 2 diabe
Expert insights. Personalized for you.
171 
Let's personalize your content